Pulse Biosciences, Inc. (NASDAQ: PLSE) Q4 2024 Earnings Call Transcript March 27, 2025 Pulse Biosciences, Inc. beats earnings ...

Abbott Park, Illinois Saturday, March 29, 2025, 13:00 Hrs [IST] ...

With PFA becoming physicians’ preferred ablation method for treating AFib, Abbott is pushing to catch up with rival systems ...

Northwestern Medicine is looking at whether wearable devices like the Apple Watch can help AFib patients reduce or eliminate ...

Background Cardiac surgery carries a heightened risk of bradyarrhythmias, but current permanent pacemaker (PPM) implantation ...

Abbott Laboratories snagged a CE mark for its Volt pulsed field ablation catheter for atrial fibrillation several months earlier than the mid-year approval expected. The Abbott Park, Ill.-based ...

Abbott is joining the worldwide race to make pulsed field ablation the standard procedure for atrial fibrillation with an ...

Though late to the party compared to other industry leaders, Abbott joins a pulsed field ablation market poised for ...

The company is first rolling out the use of the Volt system among European Union doctors who have already gained experience ...

The Volt PFA system. [Image courtesy of Abbott] Abbott (NYSE: ABT) + announced it received CE mark approval in Europe for its ...

Abbott's Volt PFA System is designed to provide a new therapy option for people battling heart rhythm disorders such as atrial fibrillationPulsed field ablation - or PFA - uses high energy electrical ...

Abbott today announced it has received CE Mark in Europe for the Volttm PFA System to treat patients battling atrial fibrillation (AFib). With the earlier-than-expected CE Mark, Abbott has begun ...